- Cancer research
- Career spotlights
- Customer stories
- Gene editing
- Single-cell analysis
- Stem cell research
- Tips and troubleshooting
- ICYMI: 2018 blog posts
- About our blog
Using Unique Molecular Tags (UMTs) in NGS experiments
Research in next-generation sequencing (NGS) is rapidly evolving, and the ability to confidently detect low-frequency alleles or differentiate between molecules is now critical to the development of highly sensitive, NGS-based assays. Unique Molecular Tags (UMTs) can be useful in many situations, providing two major utilities—error correction and molecular de-duplication.
In NGS, errors are introduced during PCR, sequencing, and base calling. The addition of UMTs allows removal of errors to reduce background noise and false-positive rate, allowing you to confidently detect rare alleles with high sensitivity and specificity. In addition, since the UMTs label each DNA fragment at the beginning, bioinformatics solutions will enable you to remove PCR duplicates, distinguish molecular duplicates, and consequently obtain a valid count of the starting molecules. This provides accurate coverage information of the genomic regions of interest. The following mini-FAQ will help you understand what UMTs are, how they work, and how they can be applied to your research.
What are UMTs?
UMTs are unique sequences used to tag individual DNA fragments prior to amplification, to enable tracking of the fragments through the library preparation, target enrichment, and the data analysis processes. In each SMARTer ThruPLEX Tag-seq kit, over 16 million UMTs are provided to ensure unique labeling of every fragment.
How do UMTs work?
For the SMARTer ThruPLEX Tag-seq Kit, we designed our proprietary stem-loop adapters to contain a unique sequence made up of degenerate bases that act as the 'tag.' The molecularly-tagged adapters are incorporated during the ligation step of the library preparation process to label the starting DNA molecules. This allows the sequencing reads to be grouped during data processing into amplification families based on their UMTs.
Through bioinformatics analysis, the reads within each amplification family are compared and PCR artifacts and sequencing errors are removed to form a consensus sequence.
When should I use UMTs?
Molecular tagged libraries are useful for confident detection of mutations below 5% allele frequency, with many researchers interested in the range around and/or below 1%. There is, however, a price to pay for higher detection sensitivity and specificity (see section below).
Conventional NGS libraries are sufficient for detecting mutations around 5% allele frequency and above; however, most PCR and sequencing errors are below this range.
What else do I need to consider when sequencing libraries with UMTs?
Redundant or deep sequencing is required to realize the full benefit of unique molecular tags. Each unique DNA fragment is sequenced many times, and the duplicate reads are compared to eliminate PCR and sequencing errors to reach a consensus sequence representing the original, unique fragment. One common method to help mitigate this issue is to use targeted sequencing approaches in order to reduce the size of the genomic target, requiring a lower number of overall sequencing reads for each sample.
Also, specific data analysis tools are required to identify duplicate reads and to generate a consensus sequence from the duplicate reads.
Back to Blog Front
Considering automating your single-cell analysis? Here are five features you should look for in a system.
Learn more about using unique molecular tags in your research for additional quality control of your PCR results.
A novel protocol that enables the detection of both SNVs and CNVs from 1-5 cells in a single, low-pass sequencing run that saves time and money.
Learn more about how the Allen Institute for Brain Science used our SMART-Seq v4 Ultra Low Input Kit for Sequencing to characterize specific cell types within human brain.
Learn how the many differences between popular scRNA-seq platforms impact your data. Here, we discuss sensitivity, read efficiency, and gene diversity (3' DE expression) data generated by the ABRF Genomics Research Group.
- Big problems from small bugs
- Using the power of RNA-seq to characterize brain cell types
- Choosing a his-tagged purification resin
- When your his-tagged constructs don't bind
- Taking the SMARTer approach to RNA-seq of FFPE tissues
- Advancing cancer research with plasma-seq
- Efficient nonviral T-cell engineering: CRISPR takes a giant step towards the clinic
- Amplifying our understanding of breast cancer metastases
- How to choose the right tools for iPSC-derived disease model development
- Cardiac transcription heirarchies
- ICYMI: 2018 blog posts
- Bringing epigenomic profiling to the single-cell biology stage
- Accelerating chromatin mapping with single-cell ATAC-seq
- Top 5 considerations when automating single-cell sequencing
- What's inside automated single-cell RNA-seq platforms?
- Women in science at TBUSA
- Career spotlight: technical writer
- Career spotlight: field applications scientist
- Career spotlight: technical support scientist
- Career spotlight: associate director of R&D
- 5 tips to make your single-cell RNA-seq experiments a success
- Maximize transduction efficiency in hematopoietic cells
- Cancer immunotherapy
- Customer spotlight: profiling transcription factors with CUT&RUN sequencing
- Web and mobile apps
- Successful knockout experiments part I
- Successful knockout experiments part II
- Using UMTs in NGS experiments
- One-step vs. two-step RT-qPCR
- Avoiding DNA contamination in PCR
- Choosing a CMO partner for stem cell therapy manufacturing
- 20 years of human stem cell research
- Better biobanking with high-throughput qPCR
- Accurate detection of SNVs and CNVs in a single, low-pass sequencing run
Takara Bio USA, Inc.
United States/Canada: +1.800.662.2566 • Asia Pacific: +1.650.919.7300 • Europe: +33.(0)1.3904.6880 • Japan: +81.(0)77.565.6999
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES. © 2019 Takara Bio Inc. All Rights Reserved. All trademarks are the property of Takara Bio Inc. or its affiliate(s) in the U.S. and/or other countries or their respective owners. Certain trademarks may not be registered in all jurisdictions. Additional product, intellectual property, and restricted use information is available at takarabio.com.